NAT10 and neoplasm: Moreover, to investigate the potential synergistic enhancement of anti‐PD‐L1 efficacy through combination treatment with NAT10 knockdown, we also monitored tumor growth after anti‐PD‐L1 antibody treatment in different groups in the model.